Related Experiment Video
Updated: Jun 3, 2026
Enrichment of Bruch's Membrane from Human Donor Eyes
Published on: November 15, 2015
Complement in age-related macular degeneration: a focus on function
D T Bradley1, P F Zipfel, A E Hughes
1Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Royal Victoria Hospital, Belfast, UK. dbradley09@qub.ac.uk
Insights
Age-related macular degeneration (AMD) involves complement system inflammation. Genetic variants in complement genes impact AMD risk and disease development, offering potential targets for prevention and treatment.
Area of Science:
- Ophthalmology
- Immunology
- Genetics
Background:
- Age-related macular degeneration (AMD) is a leading cause of vision loss in the elderly, characterized by inflammation.
- The complement system, particularly its alternative pathway, plays a critical role in AMD pathogenesis.
- Genetic variations within complement system genes are strongly associated with altered AMD risk.
Purpose of the Study:
- To review the evolution of the complement system.
- To synthesize recent findings on how genetic variants affect complement function in AMD.
- To explore the implications for AMD prevention and treatment.
Main Methods:
- Literature review of complement system evolution.
- Analysis of recent studies on complement gene variants and AMD.
- Synthesis of current knowledge on complement cascade function in AMD.
Main Results:
- Complement system proteins are central to AMD development.
- Deregulation of the alternative complement pathway drives inflammation in AMD.
- Specific genetic variants modify complement function and AMD risk.
Conclusions:
- Understanding complement system genetics is key to understanding AMD.
- Genetic insights into complement function offer pathways for novel AMD therapies.
- Targeting the complement system holds promise for AMD prevention and treatment.
Abstract:
Age-related macular degeneration (AMD) is an inflammatory disease, which causes visual impairment and blindness in older people. The proteins of the complement system are central to the development of this disease. Local and systemic inflammation in AMD are mediated by the deregulated action of the alternative pathway of the complement system. Variants in complement system genes alter an individual's risk of developing AMD. Recent studies have shown how some risk-associated genetic variants alter the function of the complement system. In this review, we describe the evolution of the complement system and bring together recent research to form a picture of how changes in complement system genes and proteins affect the function of the complement cascade, and how this affects the development of AMD. We discuss the application of this knowledge to prevention and possible future treatments of AMD.
